Burton L - Search Results

1

Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.

Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, Peng J, Lin E, Wang Y, Sosman J, Ribas A, Li J, Moffat J, Sutherlin DP, Koeppen H, Merchant M, Neve R, Settleman J. Wilson TR, et al. Among authors: burton l. Nature. 2012 Jul 26;487(7408):505-9. doi: 10.1038/nature11249. Nature. 2012. PMID: 22763448 Free PMC article.

2

HGF as a circulating biomarker of onartuzumab treatment in patients with advanced solid tumors.

Penuel E, Li C, Parab V, Burton L, Cowan KJ, Merchant M, Yauch RL, Patel P, Peterson A, Hampton GM, Lackner MR, Hegde PS. Penuel E, et al. Among authors: burton l. Mol Cancer Ther. 2013 Jun;12(6):1122-30. doi: 10.1158/1535-7163.MCT-13-0015. Epub 2013 Mar 27. Mol Cancer Ther. 2013. PMID: 23536720 Clinical Trial.

3

Battling Btk Mutants With Noncovalent Inhibitors That Overcome Cys481 and Thr474 Mutations.

Johnson AR, Kohli PB, Katewa A, Gogol E, Belmont LD, Choy R, Penuel E, Burton L, Eigenbrot C, Yu C, Ortwine DF, Bowman K, Franke Y, Tam C, Estevez A, Mortara K, Wu J, Li H, Lin M, Bergeron P, Crawford JJ, Young WB. Johnson AR, et al. Among authors: burton l. ACS Chem Biol. 2016 Oct 21;11(10):2897-2907. doi: 10.1021/acschembio.6b00480. Epub 2016 Sep 7. ACS Chem Biol. 2016. PMID: 27571029

4

Elevated Levels of BRAF^V600 Mutant Circulating Tumor DNA and Circulating Hepatocyte Growth Factor Are Associated With Poor Prognosis in Patients With Metastatic Melanoma.

Lu W, Burton L, Larkin J, Chapman PB, Ascierto PA, Ribas A, Robert C, Sosman JA, McArthur GA, Chang I, Caro I, Penuel E, Yan Y, Wongchenko MJ. Lu W, et al. Among authors: burton l. JCO Precis Oncol. 2018 Nov;2:1-17. doi: 10.1200/PO.17.00168. JCO Precis Oncol. 2018. PMID: 35135117

5

Crystallization and preliminary X-ray diffraction studies of bovine recombinant immune interferon.

Rubin JR, Burton LE. Rubin JR, et al. Among authors: burton le. J Mol Biol. 1989 Oct 20;209(4):829-31. doi: 10.1016/0022-2836(89)90611-6. J Mol Biol. 1989. PMID: 2511326

6

Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma.

Cooper LJ, Ausubel L, Gutierrez M, Stephan S, Shakeley R, Olivares S, Serrano LM, Burton L, Jensen MC, Forman SJ, DiGiusto DL. Cooper LJ, et al. Among authors: burton l. Cytotherapy. 2006;8(2):105-17. doi: 10.1080/14653240600620176. Cytotherapy. 2006. PMID: 16698684

7

Crystallization and preliminary x-ray diffraction studies of recombinant rabbit interferon-gamma.

Samudzi CT, Gribskov CL, Burton LE, Rubin JR. Samudzi CT, et al. Among authors: burton le. Biochem Biophys Res Commun. 1991 Jul 31;178(2):634-40. doi: 10.1016/0006-291x(91)90155-z. Biochem Biophys Res Commun. 1991. PMID: 1907135

8

Crystallization and preliminary characterization of three crystal forms of human recombinant transforming growth factor-alpha.

Danishefsky AT, Burton LE, Rubin JR. Danishefsky AT, et al. Among authors: burton le. Biochem Biophys Res Commun. 1992 Aug 31;187(1):146-51. doi: 10.1016/s0006-291x(05)81471-8. Biochem Biophys Res Commun. 1992. PMID: 1520295

9

Crystal structure of recombinant rabbit interferon-gamma at 2.7-A resolution.

Samudzi CT, Burton LE, Rubin JR. Samudzi CT, et al. Among authors: burton le. J Biol Chem. 1991 Nov 15;266(32):21791-7. J Biol Chem. 1991. PMID: 1939201 Free article.

10

Use of pilot plant facilities to aid validation programs.

O'Leary RM, Etcheverry T, Bezy P, Anicetti V, Burton LE. O'Leary RM, et al. Among authors: burton le. PDA J Pharm Sci Technol. 2001 Jul-Aug;55(4):230-4. PDA J Pharm Sci Technol. 2001. PMID: 11505555

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

595 results

Search Page